Aptamer Details

Back to Search Results

Human Hepatocellular carcinoma (TLS11a) (ID# 7672)

Human Hepatocellular carcinoma cell line (LH86)
7.16 nM (reported value)
Binding buffer (PBS containing 5 mM MgCl2, 4.5 mg/mL glucose, 0.1 mg/mL yeast tRNA, 1 mg/mL BSA)
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
Binds to hepatocellular carcinoma LH86 cell line. Negative control was normal liver cells, Hu1082.

Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.

Meng, L. (2012). Targeted delivery of chemotherapy agents using liver cancer-specific aptamer. PloS One, 7(4), doi: 10.1371

Have your aptamer oligo synthesized ORDER